tsn

Next in Line: A Critical Review of Placebo-Controlled Trials for PCV and IPV Vaccines

 123
5 comments
- at -
Aug. 30, 2024, 12:00 a.m.
Journalist Article

In our ongoing examination of vaccine research practices, this analysis extends the findings presented in the prior paper related to the image produced by the Informed Consent Action Network (ICAN), which highlighted the fact that no vaccine currently recommended for children by the Centers for Disease Control and Prevention (CDC) has been tested in a long-term placebo-controlled study.

That analysis according to the group’s considered as anti-vaccine activists underscored the critical gaps in long-term efficacy and safety data for these vaccines, setting the stage for a deeper dive into the specific trials conducted for individual vaccines.

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2025 - Trial Site News